SCHEMBL24496331

SCHEMBL24496331

CNS(=O)(=O)c1ccc(NCc2ccc(C(F)(F)F)cc2)c(-c2cn(C3CC3)cn2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 2/20 0.55
▸ YAP1 P46937 1/20 0.55
▸ RORC P51449 3/20 0.38
▸ TLR2 O60603 1/20 0.38
▸ TLR1 Q15399 1/20 0.38
▸ PTGS2 P35354 2/20 0.37
▸ BRD4 O60885 1/20 0.36
▸ TNNI3K Q59H18 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ ASPH Q12797 1/20 0.35
▸ RIOX2 Q8IUF8 1/20 0.35
▸ KDM8 Q8N371 1/20 0.35
▸ PDE9A O76083 2/20 0.34
▸ FLT1 P17948 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ SCN3A Q9NY46 1/20 0.34
▸ KCNQ3 O43525 1/20 0.34
▸ KCNQ2 O43526 1/20 0.34
▸ KCNQ4 P56696 1/20 0.34
▸ KCNQ5 Q9NR82 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24496086 0.91 TEAD1 (0.49) TEAD1YAP1TLR2TLR1CYP19A1
SCHEMBL29648382 0.91 TEAD1 (0.49) TEAD1YAP1TLR2TLR1CYP19A1
SCHEMBL24496290 0.88 TEAD1 (0.50) TEAD1YAP1TLR2TLR1BRD4
SCHEMBL22718121 0.88 ALOX15 (0.43) TEAD1YAP1BRD4KDM4E
SCHEMBL20779719 0.86 TEAD1 (0.74) TEAD1YAP1TLR2TLR1TNNI3K
SCHEMBL22718245 0.86 TEAD1 (0.74) TEAD1YAP1TLR2TLR1PTGS2
SCHEMBL24496092 0.85 TEAD1 (0.48) TEAD1YAP1RORCPTGS2BRD4
SCHEMBL29648434 0.84 TEAD1 (0.65) TEAD1YAP1TLR2TLR1PTGS2
SCHEMBL22718131 0.82 TEAD1 (0.58) TEAD1YAP1TLR2TLR1TNNI3K
SCHEMBL24496022 0.82 TEAD1 (0.55) TEAD1YAP1TLR2TLR1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281073-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2023-11-29 — — EP disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120353-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120353-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
Send feedback